ClinConnect ClinConnect Logo
Search / Trial NCT05395325

Clinical Effects of Combined Kinesiotaping and Steroid Injection in Stroke Patients With Hemiplegic Shoulder Pain

Launched by CHANG GUNG MEMORIAL HOSPITAL · May 24, 2022

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Hemiplegic Shoulder Pain Kinesiotaping Stroke Steroid Injection

ClinConnect Summary

This clinical trial is studying a new treatment approach for stroke patients who experience shoulder pain after their stroke. Specifically, it looks at how combining a special shoulder injection with a technique called Kinesiotaping can help reduce pain, improve movement of the arm, and enhance the overall quality of life for these patients. The goal is to find out if this combination is more effective than other treatments.

To be eligible for this study, participants must be adults aged between 20 and 80 who have had a stroke within the last six months and are experiencing shoulder pain. They should be able to move their hand slightly. However, those with a history of certain shoulder problems or other serious conditions will not be able to join. If you participate, you can expect to receive the treatment as well as regular assessments to see how well it’s working. This study is currently recruiting participants, and it could be an important step in finding better pain relief for stroke survivors.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The patients have a stroke with hemiplegia (duration is less than 6 months after stroke).
  • The patients complain about shoulder pain and there're soft tissue impairment under sonography measurement.
  • Patients who are able to perform slightly hand grasp( at least 10 degrees at metacarpophalangeal and interphalangeal joints).
  • Exclusion Criteria:
  • age is younger than 20 years old or older than 80 years old
  • previous history of upper extremity tendon or neuromuscular injury, shoulder pain, frozen shoulder or shoulder surgery before stroke,
  • any other systemic neuromuscular disease; cognition or language impairment leading to communication difficulty.
  • allergic to kinesio tape

About Chang Gung Memorial Hospital

Chang Gung Memorial Hospital, one of the largest healthcare organizations in Taiwan, is renowned for its commitment to advancing medical research and improving patient care. As a clinical trial sponsor, the hospital leverages its extensive clinical expertise and state-of-the-art facilities to conduct innovative research across various medical disciplines. With a focus on collaboration and ethical practices, Chang Gung Memorial Hospital aims to contribute to the global body of medical knowledge through rigorous clinical trials that enhance treatment options and improve health outcomes for patients.

Locations

Kaohsiung, , Taiwan

Patients applied

0 patients applied

Trial Officials

Yuchi Huang

Study Chair

Chang Gung Memorial Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials